Imre Kovesdi

12.6k total citations · 2 hit papers
141 papers, 10.4k citations indexed

About

Imre Kovesdi is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Imre Kovesdi has authored 141 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 77 papers in Genetics and 37 papers in Oncology. Recurrent topics in Imre Kovesdi's work include Virus-based gene therapy research (76 papers), Viral Infectious Diseases and Gene Expression in Insects (32 papers) and CAR-T cell therapy research (30 papers). Imre Kovesdi is often cited by papers focused on Virus-based gene therapy research (76 papers), Viral Infectious Diseases and Gene Expression in Insects (32 papers) and CAR-T cell therapy research (30 papers). Imre Kovesdi collaborates with scholars based in United States, Canada and United Kingdom. Imre Kovesdi's co-authors include Thomas J. Wickham, Ronald R. Reichel, Alena Lizonová, Joseph R. Nevins, Peter W. Roelvink, Douglas E. Brough, Joseph T. Bruder, Timothy R. Billiar, Edith Tzeng and P. W. Roelvink and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Imre Kovesdi

141 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F

1998 524 citations Peter W. Roelvink, Alena Lizonová et al. profile →
Identification of a cellular transcription factor involved in E1A trans-activation

1986 487 citations Imre Kovesdi et al. profile →

Peers

Countries citing papers authored by Imre Kovesdi

Since Specialization

Citations

This map shows the geographic impact of Imre Kovesdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imre Kovesdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imre Kovesdi more than expected).

Fields of papers citing papers by Imre Kovesdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imre Kovesdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imre Kovesdi. The network helps show where Imre Kovesdi may publish in the future.

Co-authorship network of co-authors of Imre Kovesdi

This figure shows the co-authorship network connecting the top 25 collaborators of Imre Kovesdi. A scholar is included among the top collaborators of Imre Kovesdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imre Kovesdi. Imre Kovesdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality 2022 ·Cureus ·Tibor Bakács, Rifaat Safadi, László G. Puskás, Liliána Z. Fehér, Imre Kovesdi	5
2	Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector 2012 ·PLoS ONE ·Briana J. Williams, Shilpa Bhatia, (unknown), (unknown), Jennifer L. Carroll, Xiaolin Li, (unknown), Nikolay Korokhov, Imre Kovesdi, Alexander Pereboev, David T. Curiel, J. Michael Mathis	21
3	Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid 2005 ·Journal of Clinical Investigation ·Stefan Worgall, Anja Krause, (unknown), (unknown), (unknown), Neil R. Hackett, Peter W. Roelvink, Joseph T. Bruder, Thomas J. Wickham, Imre Kovesdi, Ronald G. Crystal	89
4	Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis 2002 ·European Respiratory Journal ·H. Georg Kuhn, Uta Liebers, Christian Geßner, Axel Schumacher, Christian Witt, J. Schauer, Imre Kovesdi, G. Wolff	14
5	Periocular Injection of an Adenoviral Vector Expressing the Extracellular Portion of Aascular Endothelial Growth Factor Receptor-1 (Adsflt.10) Inhibits Choroidal Neovascularization (CNV) 2002 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), Satoru Yamamoto, Tye Deering, (unknown), Imre Kovesdi, Duncan McVey, (unknown), P. A. Campochiaro	2
6	Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy 2000 ·Journal of the American College of Cardiology ·Ran Kornowski, Martin B. Leon, Shmuel Fuchs, Yoram Vodovotz, Michael A. Flynn, David A. Gordon, Anthony Pierre, Imre Kovesdi, Joan A. Keiser, Stephen E. Epstein	105
7	Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate 2000 ·Journal of Vascular Surgery ·Melina R. Kibbe, Jianrong Li, Suhua Nie, Simon C. Watkins, Alena Lizonová, Imre Kovesdi, Richard L. Simmons, Timothy R. Billiar, Edith Tzeng	3
8	Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells 2000 ·Journal of Vascular Surgery ·Melina R. Kibbe, Suhua Nie, Dai‐Wu Seol, Imre Kovesdi, Alena Lizonová, Michel S. Makaroun, Timothy R. Billiar, Edith Tzeng	28
9	Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle 1999 ·The Journal of Gene Medicine ·J.C.T. van Deutekom, Baohong Cao, Ryan Pruchnic, Thomas J. Wickham, Imre Kovesdi, Johnny Huard	24
10	Augmentation of pulmonary host defense against Pseudomonas by FcγRIIA cDNA transfer to the respiratory epithelium 1999 ·Journal of Clinical Investigation ·(unknown), (unknown), (unknown), (unknown), Ravi Singh, Melpo Christofidou‐Solomidou, Alice Prince, Imre Kovesdi, Alan D. Schreiber, Ronald G. Crystal	5
11	CAR-dependent and CAR-independent pathways of adenovirus vector–mediated gene transfer and expression in human fibroblasts 1999 ·Journal of Clinical Investigation ·Chisa Hidaka, (unknown), Philip L. Leopold, Jeffrey M. Bergelson, Neil R. Hackett, Robert W. Finberg, Thomas J. Wickham, Imre Kovesdi, Peter Roelvink, Ronald G. Crystal	179
12	Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus 1999 ·Journal of Clinical Investigation ·Ben‐Gary Harvey, Philip L. Leopold, Neil R. Hackett, (unknown), P. Mickey Williams, (unknown), Robert J. Kaner, Barbara Ferris, Igor Gonda, Theresa D. Sweeney, Ramachandran Ramalingam, Imre Kovesdi, Steven Shak, Ronald G. Crystal	182
13	Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin 1999 ·Gene Therapy ·Olivier Harari, Thomas J. Wickham, (unknown), Imre Kovesdi, David M. Segal, Tanya Y. Huehns, Catherine Sarraf, Dorian O. Haskard	67
14	Protection from reoxygenation injury by inhibition of rac1. 1998 ·Journal of Clinical Investigation ·Kyo Sang Kim, Kazuyo Takeda, (unknown), J.B. Pracyk, Kazuo Tanaka, Yingying Zhou, Zu‐Xi Yu, V J Ferrans, (unknown), Imre Kovesdi, Kaikobad Irani, Pascal J. Goldschmidt‐Clermont, Toren Finkel	129
15	A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. 1998 ·Journal of Clinical Investigation ·J.B. Pracyk, K Tanaka, Donald D. Hegland, Kyo Sang Kim, (unknown), Ilsa I. Rovira, (unknown), (unknown), (unknown), Imre Kovesdi, (unknown), Kaikobad Irani, Toren Finkel	125
16	Interaction of the Adenovirus 14.7-kDa Protein with FLICE Inhibits Fas Ligand-induced Apoptosis 1998 ·Journal of Biological Chemistry ·Ping Chen, Jie Tian, Imre Kovesdi, Joseph T. Bruder	91
17	Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types 1996 ·Nature Biotechnology ·Thomas J. Wickham, Peter W. Roelvink, Douglas E. Brough, Imre Kovesdi	276
18	Structure of the Gene Coding for the Human Retinoic Acid-Inducible Factor, MK 1993 ·DNA and Cell Biology ·Jeanette Fairhurst, Peter J. Kretschmer, (unknown), Peter Böhlen, Imre Kovesdi	7
19	Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study 1992 ·Developmental Brain Research ·Bertrand Bloch, Elisabeth Normand, Imre Kovesdi, Peter Böhlen	49
20	The HIV-1 nef Protein Does Not Have Guanine Nucleotide Binding, GTPase, or Autophosphorylating Activities 1991 ·AIDS Research and Human Retroviruses ·Joseph M. Backer, Charmaine E. Mendola, Jeanette Fairhurst, Imre Kovesdi	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact